BAMCO Inc
NVO

BAMCO Inc’s Novo Nordisk NVO Stock Holding History

BAMCO Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,426
Closed -$1.4M – 346
2025
Q4 		$1.4M Buy
27,426
+5,985
+28% +$306K ﹤0.01% 291
2025
Q3 		$1.19M Hold
21,441
– – ﹤0.01% 298
2025
Q2 		$1.48M Sell
21,441
-14,221
-40% -$967K ﹤0.01% 281
2025
Q1 		$2.48M Buy
35,662
+5,642
+19% +$466K 0.01% 277
2024
Q4 		$2.58M Sell
30,020
-3,975
-12% -$430K 0.01% 270
2024
Q3 		$4.05M Sell
33,995
-11,987
-26% -$1.6M 0.01% 274
2024
Q2 		$6.56M Sell
45,982
-6,195
-12% -$821K 0.02% 247
2024
Q1 		$6.7M Sell
52,177
-3,070
-6% -$365K 0.02% 252
2023
Q4 		$5.72M Buy
+55,247
New +$5.46M 0.02% 258
2022
Q3 		– Sell
-106,200
Closed -$5.92M – 374
2022
Q2 		$5.92M Buy
+106,200
New +$5.89M 0.02% 277

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

BAMCO Inc's NVO Position: Q1 2026 in Review

BAMCO Inc sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 27,426 shares — an estimated $1.4M sold.

BAMCO Inc first reported a position in NVO in Q2 2022 and held it in 10 quarters. The position peaked at $6.7M in Q1 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • BAMCO Inc reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • BAMCO Inc sold 27,426 Novo Nordisk shares in Q1 2026, an estimated $1.4M.
  • BAMCO Inc first reported a position in Novo Nordisk in Q2 2022 and held it in 10 quarters.
  • BAMCO Inc's Novo Nordisk position peaked at $6.7M in Q1 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on BAMCO Inc's 13F filing for Q1 2026, filed 15 May 2026.